Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-024749
Filing Date
2024-10-04
Accepted
2024-10-04 16:07:02
Documents
1
Period of Report
2024-10-03

Document Format Files

Seq Description Document Type Size
1 form4-10042024_081058.html 4  
1 form4-10042024_081058.xml 4 4027
  Complete submission text file 0001415889-24-024749.txt   5824
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Issuer) CIK: 0001348911 (see all company filings)

EIN.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KALVISTA PHARMACEUTICALS, INC. 55 CAMBRIDGE PARKWAY, SUITE 901E CAMBRIDGE MA 02142
Business Address
Treanor Patrick (Reporting) CIK: 0001929863 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36830 | Film No.: 241354978